Is ResMed Stock a Good Investment?

ResMed Investment Advice

RMD

To provide specific investment advice or recommendations on ResMed Inc stock, we recommend investors consider the following general factors when evaluating ResMed Inc. This will help you to make an informed decision on whether to include ResMed in one of your diversified portfolios:

Examine ResMed's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research ResMed's leadership team and their track record. Good management can help ResMed navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact ResMed's business and its evolving consumer preferences.
Compare ResMed's performance and market position to its competitors. Analyze how ResMed is positioned in terms of product offerings, innovation, and market share.
Check if ResMed pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about ResMed's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in ResMed Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if ResMed Inc is a good investment.

Sell

Buy

Macroaxis provides advice on ResMed Inc to complement and cross-verify current analyst consensus on ResMed Inc. Our recommendation engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed Inc fundamentals, including its revenue, current ratio, market capitalization, as well as the relationship between the cash and equivalents and earnings per share . Given that ResMed Inc has a price to earning of 73.48 X, we recommend you to check out ResMed Inc market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance	Weak	Details
Volatility	Very steady	Details
Hype Condition	Low key	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Slowly supersedes the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Buy	Details
Financial Strenth (F Score)	Strong	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine ResMed Stock

Researching ResMed's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 61.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.85. ResMed Inc recorded earning per share (EPS) of 7.53. The entity last dividend was issued on the 7th of November 2024. The firm had 2:1 split on the 31st of August 2010.

To determine if ResMed is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ResMed's research are outlined below:

	ResMed Inc has a strong financial position based on the latest SEC filings
	About 61.0% of the company shares are owned by institutional investors
	Latest headline from news.google.com: ResMed Inc. Shares Acquired by Empowered Funds LLC - MarketBeat

ResMed Quarterly Accounts Payable

249.28 Million

ResMed uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ResMed Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ResMed's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	25th of April 2024 Upcoming Quarterly Report	View
	1st of August 2024 Next Financial Report	View
	31st of March 2024 Next Fiscal Quarter End	View
	1st of August 2024 Next Fiscal Year End	View
	31st of December 2023 Last Quarter Report	View
	30th of June 2023 Last Financial Announcement	View

Earnings surprises can significantly impact ResMed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises ResMed's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2004-02-04	2003-12-31	0.09	0.1	0.01	11
2003-08-05	2003-06-30	0.09	0.1	0.01	11
2003-04-22	2003-03-31	0.08	0.09	0.01	12
2001-05-01	2001-03-31	0.05	0.06	0.01	20
2000-10-31	2000-09-30	0.04	0.05	0.01	25
2000-05-02	2000-03-31	0.04	0.05	0.01	25
1999-04-15	1999-03-31	0.03	0.04	0.01	33
1998-11-02	1998-09-30	0.02	0.03	0.01	50

Know ResMed's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as ResMed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ResMed Inc backward and forwards among themselves. ResMed's institutional investor refers to the entity that pools money to purchase ResMed's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Charles Schwab Investment Management Inc	2024-09-30	924 K
Fidelity International Ltd	2024-06-30	780.7 K
Ubs Asset Mgmt Americas Inc	2024-09-30	742.4 K
Dimensional Fund Advisors, Inc.	2024-09-30	676.4 K
Congress Asset Management Company, Llp	2024-09-30	567.5 K
Lgt Capital Partners Ltd.	2024-06-30	564 K
Jpmorgan Chase & Co	2024-06-30	538.2 K
Tandem Investment Advisors Inc	2024-09-30	496.7 K
Coatue Management Llc	2024-09-30	473.2 K
Vanguard Group Inc	2024-09-30	18 M
Blackrock Inc	2024-06-30	11.7 M

Note, although ResMed's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ResMed's market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 35.79 B.

Market Cap

461.45 Million

ResMed's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	0.29	0.30
Return On Capital Employed	0.22	0.14
Return On Assets	0.15	0.10
Return On Equity	0.21	0.14

The company has Net Profit Margin of 0.23 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.32 %, which entails that for every 100 dollars of revenue, it generated $0.32 of operating income.

Determining ResMed's profitability involves analyzing its financial statements and using various financial metrics to determine if ResMed is a good buy. For example, gross profit margin measures ResMed's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ResMed's profitability and make more informed investment decisions.

ResMed's Earnings Breakdown by Geography

Please note, the presentation of ResMed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ResMed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ResMed's management manipulating its earnings.

Evaluate ResMed's management efficiency

ResMed Inc has Return on Asset of 0.1327 % which means that on every $100 spent on assets, it made $0.1327 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2357 %, implying that it generated $0.2357 on every 100 dollars invested. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.30, whereas Return On Capital Employed is forecasted to decline to 0.14. At present, ResMed's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 482.8 M, whereas Net Tangible Assets are forecasted to decline to about 632.7 M.

	Last Reported	Projected for Next Year
Book Value Per Share	33.08	34.74
Tangible Book Value Per Share	10.45	10.97
Enterprise Value Over EBITDA	17.57	14.80
Price Book Value Ratio	5.65	4.77
Enterprise Value Multiple	17.57	14.80
Price Fair Value	5.65	4.77
Enterprise Value	429.5 M	451 M

ResMed Inc has shown resilience through effective management strategies. Our analysis examines how these strategies influence financial outcomes and investor returns which helps in understanding the stock's long-term potential.

Dividend Yield

0.0087

Forward Dividend Yield

0.0087

Forward Dividend Rate

2.12

Beta

0.687

Basic technical analysis of ResMed Stock

As of the 25th of November, ResMed holds the Risk Adjusted Performance of 0.0681, coefficient of variation of 1233.71, and Semi Deviation of 1.55. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ResMed, as well as the relationship between them. Please check ResMed Inc information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if ResMed Inc is priced some-what accurately, providing market reflects its current price of 243.78 per share. Given that ResMed has jensen alpha of 0.1167, we recommend you to check out ResMed Inc's recent market performance to make sure the company can sustain itself at a future point.

ResMed's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ResMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on ResMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ResMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Delorefice Christopher over two months ago Acquisition by Delorefice Christopher of 267 shares of ResMed subject to Rule 16b-3
		Michael Farrell over three months ago Acquisition by Michael Farrell of 13507 shares of ResMed at 84.98 subject to Rule 16b-3
		Michael Farrell over six months ago Acquisition by Michael Farrell of 55468 shares of ResMed at 148.9 subject to Rule 16b-3
		Michael Rider over six months ago Disposition of 200 shares by Michael Rider of ResMed at 173.25 subject to Rule 16b-3
		Blaise Lucile over six months ago Insider Trading
		Ronald Taylor over a year ago Acquisition by Ronald Taylor of 1768 shares of ResMed subject to Rule 16b-3

ResMed's Outstanding Corporate Bonds

ResMed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ResMed Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ResMed bonds can be classified according to their maturity, which is the date when ResMed Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	US76119LAB71 Corp Bond US76119LAB71	View

View All ResMed Corporate Bonds

Understand ResMed's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing ResMed's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0681
	Market Risk Adjusted Performance	0.6697
	Mean Deviation	1.17
	Semi Deviation	1.55
	Downside Deviation	1.83
	Coefficient Of Variation	1233.71
	Standard Deviation	1.89
	Variance	3.56
	Information Ratio	0.0117
	Jensen Alpha	0.1167
	Total Risk Alpha	(0.15)
	Sortino Ratio	0.0121
	Treynor Ratio	0.6597
	Maximum Drawdown	12.38
	Value At Risk	(2.59)
	Potential Upside	2.08
	Downside Variance	3.33
	Semi Variance	2.41
	Expected Short fall	(1.18)
	Skewness	0.852
	Kurtosis	5.76

	Risk Adjusted Performance	0.0681
	Market Risk Adjusted Performance	0.6697
	Mean Deviation	1.17
	Semi Deviation	1.55
	Downside Deviation	1.83
	Coefficient Of Variation	1233.71
	Standard Deviation	1.89
	Variance	3.56
	Information Ratio	0.0117
	Jensen Alpha	0.1167
	Total Risk Alpha	(0.15)
	Sortino Ratio	0.0121
	Treynor Ratio	0.6597
	Maximum Drawdown	12.38
	Value At Risk	(2.59)
	Potential Upside	2.08
	Downside Variance	3.33
	Semi Variance	2.41
	Expected Short fall	(1.18)
	Skewness	0.852
	Kurtosis	5.76

Consider ResMed's intraday indicators

ResMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ResMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.01
	Daily Balance Of Power	0.0735
	Rate Of Daily Change	1.0
	Day Median Price	242.67
	Day Typical Price	243.04
	Market Facilitation Index	2.45
	Price Action Indicator	1.21
	Period Momentum Indicator	0.18
	Relative Strength Index	60.27

ResMed Corporate Filings

F4	25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
8K	21st of November 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify
10Q	25th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify
	3rd of October 2024 Other Reports	View Verify

ResMed time-series forecasting models is one of many ResMed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ResMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

ResMed Stock media impact

Far too much social signal, news, headlines, and media speculation about ResMed that are available to investors today. That information is available publicly through ResMed media outlets and privately through word of mouth or via ResMed internal channels. However, regardless of the origin, that massive amount of ResMed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of ResMed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ResMed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ResMed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ResMed alpha.

ResMed Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards ResMed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ResMed Inc Historical Investor Sentiment

Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ResMed news discussions. The higher the estimate score, the more favorable the investor's outlook on ResMed.

ResMed Corporate Directors

Ronald Taylor	Lead Independent Director	Profile
Harjit Gill	Independent Director	Profile
Carol Burt	Independent Director	Profile
Jan Witte	Independent Director	Profile

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports: